What is the Ipca Laboratories Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 11.53% of the total equity shares of Ipca Laboratories Ltd.

What is the Ipca Laboratories Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 36.60% of the total equity shares of Ipca Laboratories Ltd.

How has the Ipca Laboratories Ltd promoter holding changed?

The promoter holding in Ipca Laboratories Ltd changed from 44.72% to 44.72% during the latest reported period.

How has the Ipca Laboratories Ltd FII holding changed?

The FII holding in Ipca Laboratories Ltd changed from 10.73% to 11.53% during the latest reported period.

How has the Ipca Laboratories Ltd DII holding changed?

The DII holding in Ipca Laboratories Ltd changed from 37.37% to 36.60% during the latest reported period.

Who are the major shareholders of Ipca Laboratories Ltd?

The major shareholders of Ipca Laboratories Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Ipca Laboratories Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Ipca Laboratories Ltd public shareholding?

Public shareholders hold 7.15% of the total equity shares of Ipca Laboratories Ltd as per the latest available data.

Ipca Laboratories Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln LrgNSE

₹1,953.30

+49.80(+2.62%)

As on 23 Oct 2026 at 15:31

As of 23 Oct 2026 at 15:31, Ipca Laboratories Ltd is trading at ₹1,953.30. The 52-week range stands at ₹1,251.60–₹2,038.00, with a market cap of ₹48.27 thousand crore. At a P/E of 38.13 and a dividend yield of 0.32%, it is a large-cap stock in the Pharmaceuticals sector.